Q2: strong cash flow and signs of improving FTTH Alcadon delivered Q2 adj.
Q2e on 29 Aug, expect a slow quarter before more transactions in H2 We lower '24e-'25e EBIT by 31% a...
Redeye provides a research update following the Q2 report published by Lipum earlier today.
Acquires UK-based PDAS, adding ~4% to '25e EBITA A market leader in design, installation, and mainte...
Suominen’s Q2 revenue was higher than our estimate, while gross profit landed basically as we expect...
Suominen’s results continued gradual improvement from Q1, while fell short of Vara Research consensu...
Adj. EBITA -2% vs. ABGSCe, but very strong cash flow Q2 numbers imply no material adj.
Alisa Bank’s H1 profitability was in line with our expectations, with PTP at EUR -2.
Q2 saw the Management Company business performing well, while investment returns were lacking.
Etteplan's Q2 fell short of our estimates due to continued low customer activity.
Redeye updates its estimates after reviewing Tessin's Q2 report, which was in line with our expectat...
Redeye states that while the Q2 report held few positive surprises, all eyes are now (once again) on...
CapMan's Q2 adjusted EBIT was good on an underlying basis, with the Management company result in lin...
Paper EBITDA PLN 50m, below ABGSCe PLN 59m Group EBITDA miss driven by weaker on both paper and pulp...
Redeye thinks the financial development in Q2 was weak, with the only positive surprise (product sal...
- Solid Q2 report across the board, 1% better EBITA - More marketing campaigns in Q3 to boost the cu...
Negative growth trend persists, but could improve from Q4'24e Potential for continued gross margin i...
Etteplan's Q2 results missed our estimates across the board.
Redeye leaves a comment on Coegin Pharma’s announcement of having secured an exclusive agreement wit...
Redeye comments on Tessin’s Q2 results, which were in line with expectations.
